Manufacturer record

Ticoma Pharmacia: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Ticoma Pharmacia (Punjab) were declared Not of Standard Quality between June 2024 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: EBL-421, Cefixime, Ornidazole and Lactic Acid Bacillus Tablets (exp Mar 2028). Gorakhpur, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to declared formula in respect of Content of anhydrous Cefixime. Listed in the September 2026 alert.

Records by type

2 records linked to Ticoma Pharmacia in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jun 2024 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2024
2
Products affected
Dissolution
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2024 · 12026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Cefixime, Ornidazole and Lactic Acid Bacillus Tablets Batch EBL-421Mfg Apr 2026 · Exp Mar 2028 The sample does not conform to declared formula in respect of Content of anhydrous CefiximeOther Gorakhpur, Uttar PradeshState lab Sep 2026
MONTICET-L Tablets (Montelukast & Levocetirizine Hydrochloride Tablets) Batch TP-7581Mfg Sep 2022 · Exp Aug 2024 THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST FOR MONTELUKAST. THE SAMPLE IS OFFICIAL IN 1 P 2018 THEREFORE THE SAMPLE IS MISBRANDED VIDE SECTION 17(b) AND RULE 96 OF THE DRUGS AND COSMETICS ACT 1940 AND RULES 1945.Dissolution State Lab MaharashtraState lab Jun 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.